China Archives - CDR – Chain Drug Review

GeoVax and BravoVax to team on development of coronavirus vaccine

January 27, 2020 by Chain Drug Review BravoVax, China, coronavirus (known as 2019-nCoV), David Dodd, GeoVax Labs, Wuhan Leading Headlines, Pharmacy

ATLANTA — GeoVax Labs, a biotechnology company developing human immunotherapies and vaccines against infectious diseases and cancer, together with BravoVax, a vaccine developer in Wuhan, China, announced on Monday the signing of a Letter of Intent to jointly develop a vaccine against the new coronavirus (known as 2019-nCoV). Under the collaboration, GeoVax will use its

Alipay now available at Walgreens locations nationwide

February 13, 2019 by Chain Drug Review Alibaba’s Tmall Global marketplace, Alipay, Alipay North America, China, Richard Ashworth, Walgreens, Yulei Wang Leading Headlines, Retail News, Technology

NEW YORK – Alipay, the world’s leading digital payment platform, operated by Ant Financial Services Group, and Walgreens, Wednesday announced a collaboration that will bring Alipay’s mobile payment platform to thousands of Walgreens locations throughout the U.S. “Walgreens is focused on making shopping more convenient for our customers. This collaboration has particular significance for our